Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin.

OBJECTIVE: A major site of action for the atheroprotective drug nicotinic acid (NA) is adipose tissue, via the G-protein-coupled receptor, GPR109A. Since, adipose tissue is an active secretory organ that contributes both positively and negatively to systemic inflammatory processes associated with c...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Digby, J, McNeill, E, Dyar, O, Lam, V, Greaves, D, Choudhury, R
פורמט: Journal article
שפה:English
יצא לאור: 2010